Viewing Study NCT04393506


Ignite Creation Date: 2025-12-26 @ 2:39 PM
Ignite Modification Date: 2026-01-20 @ 3:02 PM
Study NCT ID: NCT04393506
Status: COMPLETED
Last Update Posted: 2023-11-22
First Post: 2020-05-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma
Sponsor: Shanghai Jiao Tong University School of Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Oral Cancer View
None VEGFR2 Inhibitor View
None Programmed Cell Death 1 Inhibitor View
None Inductive Therapy View
Keywords: